A simple method to prepare calcium phosphate coatings on Ti6Al4V

H. Wen,J. D. de Wijn,Q. Liu,K. de Groot,F. Cui

DOI: https://doi.org/10.1023/A:1018512612695

1997-12-01

Abstract:

What problem does this paper attempt to address?

Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila

Lanikea B. King,Marta Koch,Keith R. Murphy,Yoheilly Velazquez,William W. Ja,Seth M. Tomchik,Lanikea B King,Keith R Murphy,William W Ja,Seth M Tomchik

DOI: https://doi.org/10.1534/g3.115.026484

2016-04-01

G3 Genes|Genomes|Genetics

Abstract:Abstract Neurofibromatosis I is a common genetic disorder that results in tumor formation, and predisposes individuals to a range of cognitive/behavioral symptoms, including deficits in attention, visuospatial skills, learning, language development, and sleep, and autism spectrum disorder-like traits. The nf1-encoded neurofibromin protein (Nf1) exhibits high conservation, from the common fruit fly, Drosophila melanogaster, to humans. Drosophila provides a powerful platform to investigate the signaling cascades upstream and downstream of Nf1, and the fly model exhibits similar behavioral phenotypes to mammalian models. In order to understand how loss of Nf1 affects motor behavior in flies, we combined traditional activity monitoring with video analysis of grooming behavior. In nf1 mutants, spontaneous grooming was increased up to 7x. This increase in activity was distinct from previously described dopamine-dependent hyperactivity, as dopamine transporter mutants exhibited slightly decreased grooming. Finally, we found that relative grooming frequencies can be compared in standard activity monitors that measure infrared beam breaks, enabling the use of activity monitors as an automated method to screen for grooming phenotypes. Overall, these data suggest that loss of nf1 produces excessive activity that is manifested as increased grooming, providing a platform to dissect the molecular genetics of neurofibromin signaling across neuronal circuits.
Inverting Functions as Folds

Shin-Cheng Mu,R. Bird

DOI: https://doi.org/10.1007/3-540-45442-X_13

2002-07-08

Abstract:
Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies

Eirini-Maria Georganta,Anastasios Moressis,Efthimios M C Skoulakis,Efthimios M.C. Skoulakis

DOI: https://doi.org/10.1523/JNEUROSCI.1605-20.2021

2021-06-17

Journal of Neuroscience

Abstract:Cognitive dysfunction is among the hallmark symptoms of Neurofibromatosis 1, and accordingly, loss of the Drosophila melanogaster ortholog of Neurofibromin 1 (dNf1) precipitates associative learning deficits. However, the affected circuitry in the adult CNS remained unclear and the compromised mechanisms debatable. Although the main evolutionarily conserved function attributed to Nf1 is to inactivate Ras, decreased cAMP signaling on its loss has been thought to underlie impaired learning. Using mixed sex populations, we determine that dNf1 loss results in excess GABAergic signaling to the central for associative learning mushroom body (MB) neurons, apparently suppressing learning. dNf1 is necessary and sufficient for learning within these non-MB neurons, as a dAlk and Ras1-dependent, but PKA-independent modulator of GABAergic neurotransmission. Surprisingly, we also uncovered and discuss a postsynaptic Ras1-dependent, but dNf1-independnet signaling within the MBs that apparently responds to presynaptic GABA levels and contributes to the learning deficit of the mutants.

neurosciences
Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation

Daniella P. Hernandez,Daniela M. Cruz,Celeste S. Martinez,Larisa M. Garcia,Ashley Figueroa,Marisol Villarreal,Liya M. Manoj,Saul Lopez,Karla D. López-Lorenzo,Alejandro López-Juárez

DOI: https://doi.org/10.3390/cancers16030477

2024-01-24

Cancers

Abstract:Neurofibromatosis type 1 (NF1) is caused by mutations in the NF1 gene. The clinical presentation of NF1 includes diverse neurological issues in pediatric and adult patients, ranging from learning disabilities, motor skill issues, and attention deficit disorder, to increased risk of depression and dementia. Preclinical research suggests that abnormal neuronal signaling mediates spatial learning and attention issues in NF1; however, drugs that improve phenotypes in models show inconclusive results in clinical trials, highlighting the need for a better understanding of NF1 pathophysiology and broader therapeutic options. Most NF1 patients show abnormalities in their brain white matter (WM) and myelin, and links with NF1 neuropathophysiology have been suggested; however, no current data can clearly support or refute this idea. We reported that myelin-targeted Nf1 mutation impacts oligodendrocyte signaling, myelin ultrastructure, WM connectivity, and sensory–motor behaviors in mice; however, any impact on learning and memory remains unknown. Here, we adapted a voluntary running test—the complex wheel (CW; a wheel with unevenly spaced rungs)—to delineate fine motor skill learning curves following induction of an Nf1 mutation in pre-existing myelinating cells (pNf1 mice). We found that pNf1 mutant females experience delayed or impaired learning in the CW, while proper learning in pNf1 males is predominantly disrupted; these phenotypes add complexity to the gender-dependent learning differences in the mouse strain used. No broad differences in memory of acquired CW skills were detected in any gender, but gene-dose effects were observed at the studied time points. Finally, nitric oxide signaling regulation differentially impacted learning in wild type (WT)/pNf1, male/female mice. Our results provide evidence for fine motor skill learning issues upon induction of an Nf1 mutation in mature myelinating cells. Together with previous connectivity, cellular, and molecular analyses, these results diversify the potential treatments for neurological issues in NF1.

oncology
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment

Andrew H. Miller,Mary C. Halloran

DOI: https://doi.org/10.1242/dmm.049422

2022-08-01

Disease Models & Mechanisms

Abstract:ABSTRACT Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurogenetic disorder caused by mutations in the gene neurofibromin 1 (NF1). NF1 predisposes individuals to a variety of symptoms, including peripheral nerve tumors, brain tumors and cognitive dysfunction. Cognitive deficits can negatively impact patient quality of life, especially the social and academic development of children. The neurofibromin protein influences neural circuits via diverse cellular signaling pathways, including through RAS, cAMP and dopamine signaling. Although animal models have been useful in identifying cellular and molecular mechanisms that regulate NF1-dependent behaviors, translating these discoveries into effective treatments has proven difficult. Clinical trials measuring cognitive outcomes in patients with NF1 have mainly targeted RAS signaling but, unfortunately, resulted in limited success. In this Review, we provide an overview of the structure and function of neurofibromin, and evaluate several cellular and molecular mechanisms underlying neurofibromin-dependent cognitive function, which have recently been delineated in animal models. A better understanding of neurofibromin roles in the development and function of the nervous system will be crucial for identifying new therapeutic targets for the various cognitive domains affected by NF1.

pathology,cell biology
Skewed allele-specific expression of the NF1 gene in normal subjects: A possible mechanism for phenotypic variability in neurofibromatosis type 1

Garilyn M. Jentarra,Stephen Gabe Rice,Shannon S. Olfers,Chris Rajan,David M. Saffen,Vinodh Narayanan

DOI: https://doi.org/10.1177/0883073811423439

2012-01-01

Journal of Child Neurology

Abstract:Neurofibromatosis type 1 is an autosomal dominant disorder characterized by neurocutaneous abnormalities, learning disabilities, and attention-deficit disorder. Neurofibromatosis type 1 symptom severity can be highly variable even within families where all affected members carry the same mutation. We hypothesized that variation in the expression of the normal NF1 allele may be a mechanism that participates in producing variable phenotypes. We performed allelic expression imbalance assays on healthy control individuals to estimate the prevalence of skewed allelic expression of the NF1 gene. Approximately 30% of individuals in our sample population showed significant skewing of allelic expression away from the expected 50:50 ratio, indicating that differential regulation of the NF1 alleles occurs in a high proportion of individuals. Differences of up to 25% in allele-specific expression of the NF1 alleles were identified. In individuals with Neurofibromatosis type 1, who carry a mutant allele (haploinsufficient), this degree of expression skewing may be sufficient to modulate the phenotype.
Reduced higher dimensional temporal dynamism in neurofibromatosis type 1

Eva Mennigen,Peter Schuette,Ariana Vajdi,Laura Pacheco,Tena Rosser,Carrie E Bearden

DOI: https://doi.org/10.1016/j.nicl.2019.101692

Abstract:Neurofibromatosis type 1 (NF1) is a common single gene disorder resulting in multi-organ involvement. In addition to physical manifestations such as characteristic pigmentary changes, nerve sheath tumors, and skeletal abnormalities, NF1 is also associated with increased rates of learning disabilities, attention deficit hyperactivity disorder, and autism spectrum disorder. While there are established NF1-related structural brain anomalies, including brain overgrowth and white matter disruptions, little is known regarding patterns of functional connectivity in NF1. Here, we sought to investigate functional network connectivity (FNC) in a well-characterized sample of NF1 participants (n = 30) vs. age- and sex-matched healthy controls (n = 30). We conducted a comprehensive investigation of both static as well as dynamic FNC and meta-state analysis, a novel approach to examine higher-dimensional temporal dynamism of whole-brain connectivity. We found that static FNC of the cognitive control domain is altered in NF1 participants. Specifically, connectivity between anterior cognitive control areas and the cerebellum is decreased, whereas connectivity within the cognitive control domain is increased in NF1 participants relative to healthy controls. These alterations are independent of IQ. Dynamic FNC analysis revealed that NF1 participants spent more time in a state characterized by whole-brain hypoconnectivity relative to healthy controls. However, connectivity strength of dynamic states did not differ between NF1 participants and healthy controls. NF1 participants exhibited also reduced higher-dimensional dynamism of whole-brain connectivity, suggesting that temporal fluctuations of FNC are reduced. Given that similar findings have been observed in individuals with schizophrenia, higher occurrence of hypoconnected dynamic states and reduced temporal dynamism may be more general indicators of global brain dysfunction and not specific to either disorder.
Skewed Allele-Specific Expression of the<i>NF1</i>Gene in Normal Subjects

Garilyn M. Jentarra,Stephen Gabe Rice,Shannon Olfers,Chris Rajan,David M. Saffen,Vinodh Narayanan

DOI: https://doi.org/10.1177/0883073811423439

2011-01-01

Journal of Child Neurology

Abstract:Neurofibromatosis type 1 is an autosomal dominant disorder characterized by neurocutaneous abnormalities, learning disabilities, and attention-deficit disorder. Neurofibromatosis type 1 symptom severity can be highly variable even within families where all affected members carry the same mutation. We hypothesized that variation in the expression of the normal NF1 allele may be a mechanism that participates in producing variable phenotypes. We performed allelic expression imbalance assays on healthy control individuals to estimate the prevalence of skewed allelic expression of the NF1 gene. Approximately 30% of individuals in our sample population showed significant skewing of allelic expression away from the expected 50:50 ratio, indicating that differential regulation of the NF1 alleles occurs in a high proportion of individuals. Differences of up to 25% in allele-specific expression of the NF1 alleles were identified. In individuals with Neurofibromatosis type 1, who carry a mutant allele (haploinsufficient), this degree of expression skewing may be sufficient to modulate the phenotype.
Neurofibromin Regulates G Protein–stimulated Adenylyl Cyclase Activity

Jiayuan Tong,Frances Hannan,Yinghua Zhu,Andre Bernards,Yi Zhong

DOI: https://doi.org/10.1038/nn792

IF: 25

2002-01-01

Nature Neuroscience

Abstract:Neurofibromatosis type 1 (NF1) is a dominant genetic disorder characterized by multiple benign and malignant nervous system tumors, and by learning defects in 45% of children with NF1 mutations. Studies of neurofibromin, the protein encoded by NF1, have focused on its functions in tumorigenesis and regulation of Ras activity; however, Drosophila NF1 regulates both Ras and cyclic AMP (cAMP) pathways. Expression of a human NF1 transgene rescued cAMP-related phenotypes in NF1 mutant flies (small body size and G protein–stimulated adenylyl cyclase (AC) activity defects), and neuropeptide– and G protein–stimulated AC activity were lower in Nf1−/− as compared to Nf1+/− mouse brains, demonstrating that neurofibromin regulates AC activity in both mammals and flies.
Distinct Functional Domains of Neurofibromatosis Type 1 Regulate Immediate Versus Long-Term Memory Formation

Ivan Shun Ho,Frances Hannan,Hui-Fu Guo,Inessa Hakker,Yi Zhong

DOI: https://doi.org/10.1523/jneurosci.0933-07.2007

2007-01-01

Journal of Neuroscience

Abstract:Neurofibromatosis type 1 (NF1) is a dominant genetic disorder that causes tumors of the peripheral nervous system. In addition, >40% of afflicted children have learning difficulties. The NF1 protein contains a highly conserved GTPase-activating protein domain that inhibits Ras activity, and the C-terminal region regulates cAMP levels via G-protein-dependent activation of adenylyl cyclase. Behavioral analysis indicates that learning is disrupted in both Drosophila and mouse NF1 models. Our previous work has shown that defective cAMP signaling leads to the learning phenotype in Drosophila Nf1 mutants. In the present report, our experiments showed that in addition to learning, long-term memory was also abolished in Nf1 mutants. However, altered NF1-regulated Ras activity is responsible for this defect rather than altered cAMP levels. Furthermore, by expressing clinically relevant human NF1 mutations and deletions in Drosophila Nf1-null mutants, we demonstrated that the GAP-related domain of NF1 was necessary and sufficient for long-term memory, whereas the C-terminal domain of NF1 was essential for immediate memory. Thus, we show that two separate functional domains of the same protein can participate independently in the formation of two distinct memory components.
NF1+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1‐associated cognitive and motor impairment

Vicki J. Swier,Katherine A. White,Pedro L. Negrão de Assis,Tyler B. Johnson,Hannah G. Leppert,Mitchell J. Rechtzigel,David K. Meyerholz,Rebecca D. Dodd,Dawn E. Quelle,Rajesh Khanna,Christopher S. Rogers,Jill M. Weimer

DOI: https://doi.org/10.1111/cts.13858

2024-06-27

Clinical and Translational Science

Abstract:Cognitive or motor impairment is common among individuals with neurofibromatosis type 1 (NF1), an autosomal dominant tumor‐predisposition disorder. As many as 70% of children with NF1 report difficulties with spatial/working memory, attention, executive function, and fine motor movements. In contrast to the utilization of various Nf1 mouse models, here we employ an NF1+/ex42del miniswine model to evaluate the mechanisms and characteristics of these presentations, taking advantage of a large animal species more like human anatomy and physiology. The prefrontal lobe, anterior cingulate, and hippocampus from NF1+/ex42del and wild‐type miniswine were examined longitudinally, revealing abnormalities in mature oligodendrocytes and astrocytes, and microglial activation over time. Imbalances in GABA: Glutamate ratios and GAD67 expression were observed in the hippocampus and motor cortex, supporting the role of disruption in inhibitory neurotransmission in NF1 cognitive impairment and motor dysfunction. Moreover, NF1+/ex42del miniswine demonstrated slower and shorter steps, indicative of a balance‐preserving response commonly observed in NF1 patients, and progressive memory and learning impairments. Collectively, our findings affirm the effectiveness of NF1+/ex42del miniswine as a valuable resource for assessing cognitive and motor impairments associated with NF1, investigating the involvement of specific neural circuits and glia in these processes, and evaluating potential therapeutic interventions.

medicine, research & experimental
Effect of Neurofibromatosis Type I Mutations on a Novel Pathway for Adenylyl Cyclase Activation Requiring Neurofibromin and Ras.

F Hannan,I Ho,JJY Tong,YH Zhu,P Nurnberg,Y Zhong

DOI: https://doi.org/10.1093/hmg/ddl023

IF: 5.1214

2006-01-01

Human Molecular Genetics

Abstract:Neurofibromatosis type I (NFI) is a common genetic disorder that causes nervous system tumors, and learning and memory defects in humans, and animal models. We identify a novel growth factor stimulated adenylyl cyclase (AC) pathway in the Drosophila brain, which is disrupted by mutations in the epidermal growth factor receptor (EGFR), neurofibromin (NF1) and Ras, but not Galpha(s). This is the first demonstration in a metazoan that a receptor tyrosine kinase (RTK) pathway, acting independently of the heterotrimeric G-protein subunit Galpha(s), can activate AC. We also show that Galpha(s) is the major Galpha isoform in fly brains, and define a second AC pathway stimulated by serotonin and histamine requiring NF1 and Galpha(s), as well as a third, classical Galpha(s)-dependent AC pathway, which is stimulated by Phe-Met-Arg-Phe-amide (FMRFamide) and dopamine. Using mutations and deletions of the human NF1 protein (hNF1) expressed in Nf1 mutant flies, we show that Ras activation by hNF1 is essential for growth factor stimulation of AC activity. Further, we demonstrate that sequences in the C-terminal region of hNF1 are sufficient for NF1/Galpha(s)-dependent neurotransmitter stimulated AC activity, and for rescue of body size defects in Nf1 mutant flies.
Effects of on sleep behavior are mediated through starvation caused by deficits in SARM1 dependent NAD+ metabolism.

Folasade A Sofela,Mariela Lopez Valencia,Thomas A. Jongens,Amita Sehgal

DOI: https://doi.org/10.1101/2024.09.14.612058

2024-09-14

Abstract:Neurofibromatosis 1 (NF1) is a relatively common autosomal dominant disease which predisposes to the formation of tumors, and is also associated with behavioral phenotypes, including sleep disturbances. As loss of the NF1 protein has been recently associated with metabolic dysfunction, we explored the relationship between metabolic and behavioral phenotypes through metabolomic analysis of -null mutants. -null mutants exhibit a metabolic signature indicative of starvation, with diminished metabolites related to glucose, glycogen, and fatty acid processing and increased mRNA of , a hormone that promotes foraging during starvation. Reduced sleep in -null mutants was rescued by genetic manipulation of the AKH pathway and by a high-sucrose diet, which also partially corrected hypolipidemia, suggesting that sleep loss is due to starvation-induced foraging. Interestingly, behavioral phenotypes can be recapitulated by loss of NF1 only in the periphery and trace to mitochondrial defects that include elevated levels of the NADase SARM1. Indeed, inhibition of SARM1 activity rescues sleep behavior in -null flies. These findings suggest a novel connection between loss of NF1 and mitochondrial dysfunction caused by SARM1 hyperactivation, setting the scene for new pharmacological and dietary approaches that could provide relief to NF1 patients.

Molecular Biology
Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1

J Elliott Robinson,Gerard M Coughlin,Acacia M Hori,Jounhong Ryan Cho,Elisha D Mackey,Zeynep Turan,Tommaso Patriarchi,Lin Tian,Viviana Gradinaru

DOI: https://doi.org/10.7554/eLife.48983

IF: 7.7

2019-11-25

eLife

Abstract:Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder whose neurodevelopmental symptoms include impaired executive function, attention, and spatial learning that could be due to perturbed mesolimbic dopaminergic circuitry. However, these circuits have never been directly assayed in vivo . We employed the genetically encoded optical dopamine sensor dLight1 to monitor dopaminergic neurotransmission in the ventral striatum of NF1 mice during motivated behavior. Additionally, we developed novel systemic AAV vectors to facilitate morphological reconstruction of dopaminergic populations in cleared tissue. We found that NF1 mice exhibit reduced spontaneous dopaminergic neurotransmission that was associated with excitation/inhibition imbalance in the ventral tegmental area and abnormal neuronal morphology. NF1 mice also had more robust dopaminergic and behavioral responses to salient visual stimuli, which were stimulus-dependent, independent of learning, and rescued by optogenetic inhibition of non-dopaminergic neurons in the VTA. Overall, these studies provide a first in vivo characterization of dopaminergic circuit function in the context of NF1 and reveal novel pathophysiological mechanisms.

biology
A neurofibromatosis-1-regulated pathway is required for learning in Drosophila

Hui-Fu Guo,Jiayuan Tong,Frances Hannan,Lin Luo,Yi Zhong

DOI: https://doi.org/10.1038/35002593

IF: 64.8

2000-01-01

Nature

Abstract:The tumour-suppressor gene Neurofibromatosis 1 ( Nf1 ) encodes a Ras-specific GTPase activating protein (Ras-GAP) 1 , 2 , 3 , 4 , 5 . In addition to being involved in tumour formation 6 , 7 , NF1 has been reported to cause learning defects in humans 8 , 9 , 10 and Nf1 knockout mice 11 . However, it remains to be determined whether the observed learning defect is secondary to abnormal development. The Drosophila NF1 protein is highly conserved, showing 60% identity of its 2,803 amino acids with human NF1 (ref. 12 ). Previous studies have suggested that Drosophila NF1 acts not only as a Ras-GAP but also as a possible regulator of the cAMP pathway that involves the rutabaga ( rut )-encoded adenylyl cyclase 13 . Because rut was isolated as a learning and short-term memory mutant 14 , 15 , we have pursued the hypothesis that NF1 may affect learning through its control of the Rut-adenylyl cyclase/cAMP pathway. Here we show that NF1 affects learning and short-term memory independently of its developmental effects. We show that G-protein-activated adenylyl cyclase activity consists of NF1-independent and NF1-dependent components, and that the mechanism of the NF1-dependent activation of the Rut-adenylyl cyclase pathway is essential for mediating Drosophila learning and memory.
Cognition and behavior in adults with neurofibromatosis type 1

Anja Bos-Roubos,Hanneke van Leeuwen,Ellen Wingbermühle,Louisa van den Bosch,Lindsey Ossewaarde,Walter Taal,Laura de Graaff,Jos Egger

DOI: https://doi.org/10.3389/fneur.2024.1476472

IF: 3.4

2024-11-30

Frontiers in Neurology

Abstract:Background: Neurofibromatosis Type 1 (NF1) is a congenital neurocutaneous disorder. As NF1 is incurable and presents with a wide range of physical and mental symptoms, knowledge of neurocognitive and behavioral functioning can be an important aid in understanding their functional impact, and developing treatment options. To date, studies in children with NF1 have shown dysfunction in several domains, but much less is known about cognition and behavior in adults with NF1. The present study describes the neuropsychological phenotype of adults with NF1 based on comprehensive clinical examination of cognition and behavior across multiple functions. Methods: Participants were 62 adults with NF1 (mean age 38.2 years; SD 13.4). All underwent individual clinical neuropsychological assessment at the Center of Excellence for Neuropsychiatry as part of regular care. Scores on all individual measures were standardized into z-scores based on the corresponding normative group data. The proportions of mean z-scores in the NF1 study group were calculated according to cut-off points (±1 to ±1.5 SD; > ±1.5 SD) and compared to the expected proportions in the normal population distribution. Cognition and behavior was tested against population means constructed by bootstrapping. Results: Performance on the cognitive measures oral reading speed, visuospatial copying, visuospatial immediate recall, visual learning/imprinting, and visual memory immediate recall in the NF1 group were lower than normative means. The behavioral measures indicated higher levels of dysfunction, including psychopathology. The proportions of the NF1 study group with lower cognitive performance and higher levels of behavioral dysfunction were larger than in the normal population distributions. In addition, domain-level results revealed that intelligence, attention/speed, memory, and social cognition reflect cognitive dysfunction. Moreover, levels of emotion perception problems, experienced executive dysfunction, internalizing psychopathology (e.g., anxiety, depression), and severe fatigue were significantly higher compared to the simulated population sample. The mean level of emotion regulation (coping strategies) did not differ significantly from the population. Conclusion: Identified cognitive and behavioral dysfunction in multiple domains indicates high vulnerability in adults with NF1 and underscores the importance of individualized neuropsychological assessment and treatment. Further research on the relationships between cognition and behavior (including fatigue) in NF1 is warranted.

neurosciences,clinical neurology
Impairment of spontaneous alternation performance by an NMDA antagonist: attenuation with non-NMDA treatments.

D. Walker,P. E. Gold

DOI: https://doi.org/10.1016/0163-1047(92)90952-Z

1992-07-01

Behavioral and Neural Biology

Abstract:
Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction

Junwang Xu,Fraz A Ismat,Tao Wang,Min Min Lu,Nicole Antonucci,Jonathan A Epstein

DOI: https://doi.org/10.1161/CIRCRESAHA.109.201509

2009-07-31

Abstract:Rationale: Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder with a broad array of clinical manifestations, including benign and malignant tumors, and characteristic cutaneous findings. NF1 patients also have an increased incidence of cardiovascular diseases, including obstructive vascular disorders and hypertension. The disease gene, NF1, encodes neurofibromin, a ubiquitously expressed protein that acts, in part, as a Ras-GAP (GTP-ase activating protein), downregulating the activity of activated Ras protooncogenes. In animal models, endothelial and smooth muscle expression of the disease gene is critical for normal heart development and the prevention of vascular disease, respectively. Objective: To determine the role of NF1 in the postnatal and adult heart. Methods and results: We generated mice with homozygous loss of the murine homolog Nf1 in myocardium (Nf1mKO) and evaluated their hearts for biochemical, structural, and functional changes. Nf1mKO mice have normal embryonic cardiovascular development but have marked cardiac hypertrophy, progressive cardiomyopathy, and fibrosis in the adult. Hyperactivation of Ras and downstream pathways are seen in the heart with the loss of Nf1, along with activation of a fetal gene program. Conclusions: This report describes a critical role of Nf1 in the regulation of cardiac growth and function. Activation of pathways known to be involved in cardiac hypertrophy and dysfunction are seen with the loss of myocardial neurofibromin.
Global loss of Neuron‐specific gene 1 causes alterations in motor coordination, increased anxiety, and diurnal hyperactivity in male mice

Roman Austin,Praveen Chander,Amber J. Zimmerman,Malene Overby,Laura Digilio,Chan Choo Yap,David N. Linsenbardt,Heidi Kaastrup Müller,Jason P. Weick

DOI: https://doi.org/10.1111/gbb.12816

2022-05-24

Abstract:Neuron‐specific gene family member 1 (NSG1) is a small endolysosomal protein that is critical for trafficking multiple receptors and signaling molecules in neurons. Here we demonstrate that NSG1 KO animals show gait abnormalities, consistent with unique NSG expression in Cerebellum. NSG1 KO also caused increased anxiety in elevated mazes, and hyperactivity during subjective daytime, suggesting more global effects on cortical and subcortical networks. The Neuron‐specific gene family (NSG1‐3) consists of small endolysosomal proteins that are critical for trafficking multiple receptors and signaling molecules in neurons. NSG1 has been shown to play a critical role in AMPAR recycling from endosomes to plasma membrane during synaptic plasticity. However, to date nothing is known about whether NSG1 is required for normal behavior at an organismal level. Here we performed a battery of behavioral tests to determine whether loss of NSG1 would affect motor, cognitive, and/or affective behaviors, as well as circadian‐related activity. Consistent with unique cerebellar expression of NSG1 among family members, we found that NSG1 was obligatory for motor coordination but not for gross motor function or learning. NSG1 knockout (KO) also altered performance across other behavioral modalities including anxiety‐related and diurnal activity paradigms. Surprisingly, NSG1 KO did not cause significant impairments across all tasks within a given modality, but had specific effects within each modality. For instance, we found increases in anxiety‐related behaviors in tasks with multiple stressors (e.g., elevation and exposure), but not those with a single main stressor (e.g., exposure). Interestingly, NSG1 KO animals displayed a significant increase in locomotor activity during subjective daytime, suggesting a possible impact on diurnal activity rhythms or vigilance. Surprisingly, loss of NSG1 had no effect on hippocampal‐dependent learning despite previous studies showing deficits in CA1 long‐term potentiation. Together, these findings do not support a role of NSG1 in hippocampal‐dependent learning, but support a role in mediating proper neuronal function across amygdalar and cerebellar circuits.
Conditional deletion of Pten tumor suppressor gene and activation of K Ras oncogene result in the development of Neurofibromatoses

Caroline Gregorian,Jonathan Nakashima,Annie Liu,Matthias Groszer,Rachel Kim,Paul Mischel,Michael Sofroniew,Xin Liu,Hong Wu

2007-01-01

Abstract:3863Neurofibromatoses (NFs) are a set of inherited disorders designated as Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), and Schwannomatosis, that result in a variety of tumors in the central and peripheral nervous systems (CNS and PNS). NF1 and NF2 are caused by mutations in the neurofibromin (Nf1) or neurofibromin-2 (Nf2, or merlin) gene, respectively, which act as negative regulators of RAS activity. Nf1+/-, Nf2+/-, and conditional knockout lines for either gene fail to recapitulate the full disease spectrum observed in humans. To address the involvement of other signaling pathways with those controlled by NF1 and NF2, we utilized Cre-Lox technology to perturb RAS/RAF/MAPK and PI3K/AKT/mTOR, two of the major signaling pathways involved in tumorigenesis of the nerve system, individually and in combination. The resulting mouse model accurately reflects the human clinical …

A simple method to prepare calcium phosphate coatings on Ti6Al4V

Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila

Inverting Functions as Folds

Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies

Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation

Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment

Skewed allele-specific expression of the NF1 gene in normal subjects: A possible mechanism for phenotypic variability in neurofibromatosis type 1

Reduced higher dimensional temporal dynamism in neurofibromatosis type 1

Skewed Allele-Specific Expression of the<i>NF1</i>Gene in Normal Subjects

Neurofibromin Regulates G Protein–stimulated Adenylyl Cyclase Activity

Distinct Functional Domains of Neurofibromatosis Type 1 Regulate Immediate Versus Long-Term Memory Formation

NF1+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1‐associated cognitive and motor impairment

Effect of Neurofibromatosis Type I Mutations on a Novel Pathway for Adenylyl Cyclase Activation Requiring Neurofibromin and Ras.

Effects of on sleep behavior are mediated through starvation caused by deficits in SARM1 dependent NAD+ metabolism.

Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1

A neurofibromatosis-1-regulated pathway is required for learning in Drosophila

Cognition and behavior in adults with neurofibromatosis type 1

Impairment of spontaneous alternation performance by an NMDA antagonist: attenuation with non-NMDA treatments.

Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction

Global loss of Neuron‐specific gene 1 causes alterations in motor coordination, increased anxiety, and diurnal hyperactivity in male mice

Conditional deletion of Pten tumor suppressor gene and activation of K Ras oncogene result in the development of Neurofibromatoses